Path Ex Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Path Ex General Information

Description

Developer of an extracorporeal blood-cleansing device designed for the diagnosis and treatment of sepsis. The company's device selectively removes pathogens, including multidrug-resistant bacteria and endotoxin from circulating blood, enabling health professionals to eliminate intact bacteria from the blood rather than trying to kill the infection.

Contact Information

Website
www.pathex.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite J
  • Houston, TX 77021
  • United States
+1 (412)
Primary Industry
Other Devices and Supplies
Corporate Office
  • 2450 Holcombe Boulevard
  • Suite J
  • Houston, TX 77021
  • United States
+1 (412)

Path Ex Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Path Ex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Secondary Transaction - Private 01-May-2026 Completed Pre-Clinical Trials
18. Seed Round 25-Apr-2025 Completed Pre-Clinical Trials
17. Grant 23-Sep-2021 Completed Pre-Clinical Trials
16. Seed Round 30-Jun-2021 Completed Pre-Clinical Trials
15. Grant 05-Feb-2021 Completed Pre-Clinical Trials
14. Accelerator/Incubator 22-Oct-2020 Completed Pre-Clinical Trials
13. Seed Round 01-Feb-2020 Completed Startup
12. Accelerator/Incubator 07-Nov-2019 Completed Startup
11. Accelerator/Incubator 01-Jan-2019 $875K Completed Startup
10. Seed Round 08-Jan-2019 $700K $875K Completed Startup
To view Path Ex’s complete valuation and funding history, request access »

Path Ex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-1
Seed-2 318,807 $0.000010 $0.74 $9.31 $9.31 1x $9.31 13.37%
Seed 281,199 $0.000010 $0.37 $4.65 $4.65 1x $4.65 11.8%
To view Path Ex’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Path Ex Patents

Path Ex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3870969-A1 Method for the capture and isolation of disease material from flowing matter Inactive 24-Oct-2018
EP-3870969-A4 Method for the capture and isolation of disease material from flowing matter Inactive 24-Oct-2018
US-20210220818-A1 Method for the capture and isolation of disease material from flowing matter Inactive 24-Oct-2018
WO-2020086761-A1 Method for the capture and isolation of disease material from flowing matter Inactive 24-Oct-2018
JP-2024028779-A Device for capture and removal of disease material from fluids Pending 05-Jan-2018 A61M1/3679
To view Path Ex’s complete patent history, request access »

Path Ex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Path Ex Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fitz Gate Ventures Venture Capital Minority
IAG Capital Partners Venture Capital Minority
Oakwood Circle Ventures Venture Capital Minority
Symbiotic Ventures Venture Capital Minority
MedTech Innovator Accelerator/Incubator
You’re viewing 5 of 14 investors. Get the full list »

Path Ex FAQs

  • When was Path Ex founded?

    Path Ex was founded in 2017.

  • Where is Path Ex headquartered?

    Path Ex is headquartered in Houston, TX.

  • What is the size of Path Ex?

    Path Ex has 8 total employees.

  • What industry is Path Ex in?

    Path Ex’s primary industry is Other Devices and Supplies.

  • Is Path Ex a private or public company?

    Path Ex is a Private company.

  • What is Path Ex’s current revenue?

    The current revenue for Path Ex is .

  • How much funding has Path Ex raised over time?

    Path Ex has raised $12.5M.

  • Who are Path Ex’s investors?

    Fitz Gate Ventures, IAG Capital Partners, Oakwood Circle Ventures, Symbiotic Ventures, and MedTech Innovator are 5 of 14 investors who have invested in Path Ex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process